Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer

doi:10.3748/wjg.v23.i47.8345

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 47

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8905)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

625

WORD

244

HTML

5053

Figures (1-3)

332

Tables (1-6)

231

Sum=6485

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1042

Download

1378

Sum=2420

Dec 21, 2017 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (149)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Dec 21, 2017; 23(47): 8345-8354
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8345

Table 4 Clinicopathological factors of plasma samples of patients with pancreatic cancer and expression of circ-LDLRAD3

Characteristic	n (%)
Age (yr)
≥ 60	15 (48.4)
< 60	16 (51.6)
Gender
Male	19 (61.3)
Female	12 (38.7)
Tumor diameter (cm)
≤ 4	21 (67.7)
> 4	10 (32.3)
CA19-9
Positive	25 (87.1)
Negative	4 (12.9)
CEA
Positive	10 (32.3)
Negative	21 (67.7)
Clinical stage
IA	5 (16.1)
IB	6 (19.4)
IIA	6 (19.4)
IIB	5 (16.1)
III	6 (19.4)
IV	3 (9.7)
T classification
T1	5 (16.1)
T2	15 (48.4)
T3	9 (29.0)
T4	2 (6.5)
N classification
N0	21 (67.7)
N1	6 (19.4)
N2	4 (12.9)
Metastasis
M0	28 (90.3)
M1	3 (9.7)
Venous invasion
No	19 (61.3)
Yes	12 (38.7)
Lymphatic invasion
No	21 (67.7)
Yes	10 (32.3)
Expression of circ-LDLRAD3
Low expression	9 (29)
High expression	22 (71)

Citation: Yang F, Liu DY, Guo JT, Ge N, Zhu P, Liu X, Wang S, Wang GX, Sun SY. Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. World J Gastroenterol 2017; 23(47): 8345-8354
URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8345.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i47.8345